{"name":"Harbor Therapeutics","slug":"harbor-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxOLVp3UE1SUjVFeEg2YVR5X2NvS2JHY2lCdFdmUmdkU2hOTXQ4eGZjaW9LOERPbEM5eC1SSkY2OVFHYUlxYUh2Q21kWGZ4SXpFY2p2M0puQzBXaFFUcG5Vbk10SmlRSXUwN1I2aWtuZTJrdUVYS1NYeWRqX1lGd2JIOHF0VWlmMVdKYVNpRjBKelpQbGVfcWJjSHUteWVFWnduYzFqeGo1amFzSmJzTFdfaUJQUXVZNmdtc2xkSnlaVDIzVDVPR2tjek1Zcw?oc=5","date":"2026-03-30","type":"trial","source":"Reuters","summary":"Viridian sinks as eye disease drug disappoints on efficacy despite trial success - Reuters","headline":"Viridian sinks as eye disease drug disappoints on efficacy despite trial success","sentiment":"negative"},{"url":"https://news.google.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?oc=5","date":"2026-02-27","type":"trial","source":"Insider Monkey","summary":"Jazz Pharmaceuticals plc (JAZZ) Jumps Nearly 30% on Strong Q3 and Cancer Drug Trial Progress - Insider Monkey","headline":"Jazz Pharmaceuticals plc (JAZZ) Jumps Nearly 30% on Strong Q3 and Cancer Drug Trial Progress","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-21","type":"pipeline","source":"South China Morning Post","summary":"Harbour BioMed stake in US drug developer shows Chinese firms’ growing clout - South China Morning Post","headline":"Harbour BioMed stake in US drug developer shows Chinese firms’ growing clout","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPcjZ1Snp6Qk5RdTYzN1VDY3g2UnlvUWthSm9TY2V2b1RkTE1YdWZUVExZRmp2T3NqS3ozREVPbXF2ODM3aEJYMkJ1V19zaWNJTWZheldzTDVLRy1FMGdST2R6S3VvcGd5RmJuRWZNemZDUGhFcWtoeXdUVG9lVEhNV3hqRTJDWFMwTGpIb0UwR1YzTjJOTmNzeVF5NUQ4Zm5hVU1YdUhJS3ptb2FuOE9wYVlhS3ZWZw?oc=5","date":"2026-01-19","type":"deal","source":"Contract Pharma","summary":"Harbour BioMed Exercises Agreement to Buy Spruce Biosciences Common Stock - Contract Pharma","headline":"Harbour BioMed Exercises Agreement to Buy Spruce Biosciences Common Stock","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQVTNNMUtEajN2ODZ0OHVUTy1wWlBlVGN6RWo4Q0FHYUpRV0VyQm5PTWlLVk5pSVlkb05kTF9vMWxqNW9RSVptODNpWVc4SUw1NjJIN3plZEhyNXZTdEhiZzBnY1pFLUpCNDhDUzVXWExmMm1jam9mVTJNakFKaUdxb2xMYVZLT215TUpoNkZQSDU5Zw?oc=5","date":"2025-12-17","type":"pipeline","source":"BioSpace","summary":"BMS Forges $1B+ Antibody Alliance With Chinese Firm Harbour - BioSpace","headline":"BMS Forges $1B+ Antibody Alliance With Chinese Firm Harbour","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPNzlWN0hDdlNncEdhY2FoUUlQMm5ROTQtaVkxUUlsVVA3aTlDMnJXVnZkeWxrNG1qMmowWjAxLTlWc2Vaa1NZSU1SVlBKNHNHejZjZXFoTjdDTEE4VmktX2VyMTdtaENCMXBxQUlTbGFPZG9qcmV0VGphbHFVMmtrcHl5dFE5RjFSSG0wMzdtdkpOMjloVDhVUDAwM0dOQjNpZVo2UDFVQ1ZIcTQ?oc=5","date":"2025-12-17","type":"deal","source":"Fierce Biotech","summary":"Harbour BioMed docks with BMS in antibody discovery, development deal worth up to $1.1B - Fierce Biotech","headline":"Harbour BioMed docks with BMS in antibody discovery, development deal worth up to $1.1B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxOdU9SeWpPeVFMVWQxSlIzTnZRRzR5anQzTXllWU85MGtOM0pHM2NNR0xTR3hRSDRNaDlUWnRlbnBWXzNrZV9XR3ZVT1ZLTEdQRnl2ZzczUjlYQV85Y0puX2lIMUgyT3NXT3VqY3RpOEZFQlBjbm9QTzZwUHo1eFVMaHpaTE9lWTkyemM4R1RvN2s3RTBfRUloTW4yMHljVVRBem5FZThtbEQyVVFHZ3RrdUlnS3o5b0VGTjZsbGJEWHJNclVkN3ZvdElSRkxKWmhhcE4wNTczSEVxZ0FWWGlkSA?oc=5","date":"2025-11-24","type":"pipeline","source":"businesswire.com","summary":"Arrowhead Pharmaceuticals Earns $200 Million Milestone Payment from Sarepta Therapeutics - businesswire.com","headline":"Arrowhead Pharmaceuticals Earns $200 Million Milestone Payment from Sarepta Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1LcHVHWEJXb2VzbUtWVEdEa1Mxc0pmcGxhZ2d1OUlrcVY2OEdlbjZnU3V0dXFfYzRYcHhpQ2RjS1BfZkxYbjdPWm50enJsZ0s4Z1N4YUNmeW5IaGh0djlv?oc=5","date":"2025-08-29","type":"pipeline","source":"Nature","summary":"Antibody discovery for next-generation biologics at Harbour BioMed and Nona Biosciences - Nature","headline":"Antibody discovery for next-generation biologics at Harbour BioMed and Nona Biosciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOYTliWFFEdkRteFpDQVJZbXFTNEVwazVLNmpKOE5Wek5RS3ZtUUJUUU56dGNBRV8zLXNJdnd1WHVTdlJrRlNEb0lQNTR1UGt2bEY2QmpGR0N6MG81YzZFalRzc2l6bG8zakVGYWpFMWRrNHN1WHFIY3JyNHgxbTE2dnUzSE9ieU1DMENYQQ?oc=5","date":"2025-06-23","type":"deal","source":"Pharmaceutical Technology","summary":"Harbour BioMed partners with Otsuka on new T-cell therapy - Pharmaceutical Technology","headline":"Harbour BioMed partners with Otsuka on new T-cell therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxOYzhSdFhUci1CRUcyVVlhNFRZSG9LeHAwSHFlWHNUX2tTUDdfOURKUTFNNk5IUkR6SWE4V0U0bUNxNGJhX0tqMm1udHdiem9IWUtVNEtaNVdCQ0Z3T25ObU5hRW9XUGhPMlp5cURNWXJRR1V1WFV6R1NtekQ5WjhzVlFkaFdSREpvaXBVbzZDVGRDeVd4VzB4RkF2ckVNbFBXSE1tSGhaWVc1SXFrdFZPcVpBZVhIeDV5QTdvcEJRV2hIc1VXUS1vUWJsVDRDTzVIT1RiOXI0QnEyemYtVGJxQnBpWjVzVE9JVE9YWGpoUTZ4R1ZfdUxtWDBSNA?oc=5","date":"2025-06-22","type":"deal","source":"prnewswire.com","summary":"Harbour BioMed Enters Global Strategic Collaboration with Otsuka to Advance BCMAxCD3 Bispecific T-Cell Engagers - prnewswire.com","headline":"Harbour BioMed Enters Global Strategic Collaboration with Otsuka to Advance BCMAxCD3 Bispecific T-Cell Engagers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQQW4zOC1PNVlIQ2lhS2c0cWNnNE5VbjQzMFpmRW9wNVUxTGVNdGNZWVYtM3dsdkZwZGUwSVgxcnlwMVZiRmJ5dVVMV3pnTGZQeGJLa0otMXZZTEFnbHNoRE9RTmNpOHhVMDFCUDdDc25vdVl0MmhuTy1VUXVTOURxM0tTZm56aHU0akw2bDVVb1RnSDNN?oc=5","date":"2025-06-10","type":"pipeline","source":"IPWatchdog.com","summary":"Hatch-Waxman Safe Harbor: Lessons from Recent Court Precedent - IPWatchdog.com","headline":"Hatch-Waxman Safe Harbor: Lessons from Recent Court Precedent","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNS2I4WnVlTHIxVjIxV0RYS2Fmb1VoemNvcnMwNUdvR19sem1xazlpMlJLSDNTRVBqTUNUR05mQTktQVpOWTRidEJaelplV2NvYmxKc2MxM09ZYmdoWTVTLUFWUWxZODBZWjFQbTkydTlOYmJnQTlncllRdFNjR1lvZVZvN0I3ZzNKMUE?oc=5","date":"2025-05-13","type":"patent","source":"JD Supra","summary":"Jazz Pharma. v. Avadel CNS Pharma: Federal Circuit Applies a Fact-Specific Approach to the Patent Infringement Safe Harbor - JD Supra","headline":"Jazz Pharma. v. Avadel CNS Pharma: Federal Circuit Applies a Fact-Specific Approach to the Patent Infringement Safe Harb","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}